Lundwall Kristina, Jekell Andreas, Desta Liyew, Jacobson Stefan H, Kahan Thomas, Spaak Jonas
Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.
Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden.
Blood Press. 2022 Dec;31(1):91-99. doi: 10.1080/08037051.2022.2064266.
The dismal combination of hypertension and chronic kidney disease potentiates both cardiovascular disease and loss of renal function. Research points to the importance of arterial and left ventricular stiffening in this process but few studies have compared aspects of central and peripheral hemodynamics in relation to renal function in hypertension.
We investigated 107 hypertensive individuals with renal function ranging from normal to severe dysfunction with pulse wave analysis to obtain central blood pressures (BP), augmentation index, carotid-femoral and carotid-radial pulse wave velocity (cfPWV, crPWV), aortic-to-brachial stiffness mismatch (cfPWV/crPWV), endothelial function by forearm flow-mediated vasodilation and myocardial microvascular function by subendocardial viability ratio, and indices of left ventricular structure (left ventricular mass index and relative wall thickness, RWT) and diastolic function (left atrial volume index, E/A, and E/é).
Mean age was 58 years, BP 149/87 mm Hg, 9% had cardiovascular disease, and 31% were on antihypertensive treatment. Mean estimated glomerular filtration rate (eGFR) was 74 (range 130-21) ml/min × 1.73 m. Whereas cfPWV and cfPWV/crPWV were independently related to eGFR ( = -0.20, = 0.002, = -0.16, = 0.01), central diastolic BP ( = 0.21, = 0.04), RWT ( = -0.34, = 0.001), E/é ( = -0.39, < 0.001) and E/A ( = 0.27, = 0.01) were related to eGFR in bivariate correlations, but these findings were not retained in multivariate analyses. Remaining markers of hypertensive heart disease and measures of microvascular function were not related to eGFR.
Increased aortic stiffness and aortic-to-brachial stiffness mismatch are independently related to reduced eGFR in hypertensive patients, suggesting an important role for aortic stiffness in the evolution of hypertension-mediated renal dysfunction. Aortic stiffness and aortic-brachial stiffness mismatch may be useful early markers to find hypertensive patients at risk for decline in renal function.
高血压与慢性肾脏病的不良组合会加剧心血管疾病和肾功能丧失。研究指出动脉和左心室僵硬度在这一过程中具有重要性,但很少有研究比较高血压患者中心血流动力学和外周血流动力学与肾功能相关的方面。
我们对107名肾功能从正常到严重受损的高血压患者进行了研究,采用脉搏波分析来获取中心血压(BP)、增强指数、颈股动脉和颈桡动脉脉搏波速度(cfPWV、crPWV)、主动脉与肱动脉僵硬度不匹配(cfPWV/crPWV),通过前臂血流介导的血管舒张评估内皮功能,通过心内膜下存活比评估心肌微血管功能,以及左心室结构指标(左心室质量指数和相对室壁厚度,RWT)和舒张功能指标(左心房容积指数、E/A和E/é)。
平均年龄为58岁,血压为149/87 mmHg,9%患有心血管疾病,31%正在接受抗高血压治疗。平均估算肾小球滤过率(eGFR)为74(范围130 - 21)ml/min×1.73 m²。虽然cfPWV和cfPWV/crPWV与eGFR独立相关(r = -0.20,P = 0.002,r = -0.16,P = 0.01),中心舒张压(r = 0.21,P = 0.04)、RWT(r = -0.34,P = 0.001)、E/é(r = -0.39,P < 0.001)和E/A(r = 0.27,P = 0.01)在双变量相关性中与eGFR相关,但这些结果在多变量分析中未保留。高血压性心脏病的其余标志物和微血管功能指标与eGFR无关。
主动脉僵硬度增加和主动脉与肱动脉僵硬度不匹配与高血压患者eGFR降低独立相关,提示主动脉僵硬度在高血压介导的肾功能障碍进展中起重要作用。主动脉僵硬度和主动脉 - 肱动脉僵硬度不匹配可能是发现有肾功能下降风险的高血压患者的有用早期标志物。